Mangalam Drugs and Organics Share Price
Start SIP in Mangalam Drugs and Organics
Start SIPMangalam Drugs and Organics Performance
Day Range
- Low 119
- High 123
52 Week Range
- Low 91
- High 145
- Open Price119
- Previous Close118
- Volume18563
Mangalam Drugs And Organics Investment Rating
-
Master Rating:
-
Mangalam Drugs & Orgs. has an operating revenue of Rs. 276.11 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of -3% needs improvement, ROE of -6% is poor and needs improvement. The company has a reasonable debt to equity of 10%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It has recently broken out of a base in its weekly chart but failed to keep its momentum and is trading around -10% from the pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 47 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 76 | 102 | 97 | 82 | 87 | 90 |
| Operating Expenses Qtr Cr | 68 | 91 | 90 | 79 | 91 | 91 |
| Operating Profit Qtr Cr | 8 | 12 | 7 | 2 | -3 | 0 |
| Depreciation Qtr Cr | 4 | 4 | 4 | 4 | 3 | 3 |
| Interest Qtr Cr | 4 | 4 | 3 | 3 | 3 | 3 |
| Tax Qtr Cr | -2 | 0 | 0 | -1 | -1 | -1 |
| Net Profit Qtr Cr | 3 | 4 | 1 | -4 | -10 | -4 |
Mangalam Drugs and Organics Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹125.14
- 50 Day
- ₹123.43
- 100 Day
- ₹118.30
- 200 Day
- ₹113.58
- 20 Day
- ₹127.29
- 50 Day
- ₹124.88
- 100 Day
- ₹115.65
- 200 Day
- ₹110.34
Mangalam Drugs and Organics Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 123.81 |
| Second Resistance | 125.35 |
| Third Resistance | 127.81 |
| RSI | 45.47 |
| MFI | 22.69 |
| MACD Single Line | -0.41 |
| MACD | -1.76 |
| Support | |
|---|---|
| First Support | 119.81 |
| Second Support | 117.35 |
| Third Supoort | 115.81 |
Mangalam Drugs and Organics Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 25,215 | 1,693,944 | 67.18 |
| Week | 38,018 | 2,241,138 | 58.95 |
| 1 Month | 78,713 | 4,551,180 | 57.82 |
| 6 Month | 101,718 | 5,472,447 | 53.8 |
Mangalam Drugs and Organics Result Highlights
Mangalam Drugs and Organics Synopsis
NSE-Medical-Generic Drugs
Mangalam Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 372.25 Cr. and Equity Capital is Rs. 15.83 Cr. for the Year ended 31/03/2023. Mangalam Drugs and Organics Ltd. is a Public Limited Listed company incorporated on 18/04/1972 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1972PLC116413 and registration number is 116413.| Market Cap | 187 |
| Sales | 358 |
| Shares in Float | 0.79 |
| No of funds | 4 |
| Yield | 0.68 |
| Book Value | 1.32 |
| U/D Vol ratio | 2 |
| LTDebt / Equity | 9 |
| Alpha | -0.01 |
| Beta | 0.95 |
Mangalam Drugs and Organics Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 50.32% | 50.32% | 50.32% | 50.32% |
| Foreign Portfolio Investors | 0.21% | 0.26% | 0.1% | 0.1% |
| Financial Institutions/ Banks | ||||
| Individual Investors | 44.7% | 44.22% | 44.44% | 44.55% |
| Others | 4.77% | 5.2% | 5.14% | 5.03% |
Mangalam Drugs and Organics Management
| Name | Designation |
|---|---|
| Mr. Govardhan M Dhoot | Chairman & Managing Director |
| Mr. Brijmohan M Dhoot | Whole Time Director |
| Mr. Rakesh K Milwani | Non Exe.Non Ind.Director |
| Mr. Rukmesh P Dhandhania | Independent Director |
| Mrs. Nidhi S Mundada | Independent Director |
| Mr. Praveen Saxena | Independent Director |
Mangalam Drugs and Organics Forecast
Price Estimates
Mangalam Drugs and Organics Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-13 | Quarterly Results | |
| 2024-05-21 | Audited Results | |
| 2024-03-15 | Others | Inter alia to consider and approve: The proposal of Scheme of Merger. |
| 2024-02-13 | Quarterly Results | |
| 2023-11-08 | Quarterly Results |
Mangalam Drugs and Organics FAQs
What is Share Price of Mangalam Drugs and Organics ?
Mangalam Drugs and Organics share price is ₹122 As on 09 October, 2024 | 18:51
What is the Market Cap of Mangalam Drugs and Organics ?
The Market Cap of Mangalam Drugs and Organics is ₹193.5 Cr As on 09 October, 2024 | 18:51
What is the P/E ratio of Mangalam Drugs and Organics ?
The P/E ratio of Mangalam Drugs and Organics is 61 As on 09 October, 2024 | 18:51
What is the PB ratio of Mangalam Drugs and Organics ?
The PB ratio of Mangalam Drugs and Organics is 1.4 As on 09 October, 2024 | 18:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.